Abstract
The adverse effect of neoadjuvant chemoradiotherapy on the postoperative course in esophageal cancer was studied in 9 patients undergoing neoadjuvant chemoradiotherapy preceding surgery for thoracic esophageal carcinoma possibly involving adjacent organs (neoadjuvant group), and 13 patients undergoing surgery without neoadjuvant therapy for same disease (control group). The two groups were compared for volume of intraoperative hemorrhage, surgical duration, frequency of postoperative morbidity, and for postoperative changes in blood platelet counts, and serum thrombopoietin and interleukin-6 levels. Mean intraoperative blood loss was 1121 g (580–1,662 g) in the neoadjuvant group and 546.5 g (274.7–778.3 g) in controls group (Student’s T test: p < 0.01). No significant difference was seen found between the two groups in the degree of postoperative deterioration in cardiopulmonary function or in interleukin-6 levels. Blood platelet counts decreased in both groups until postoperative day 7, but recovery on postoperative day 14 was significantly depressed in the neoadjuvant group compared to controls. Serum thrombopoietin levels were higher in the neoadjuvant group than in controls (Mann-Whitney U-test: p < 0.05). We found that neoadjuvant chemoradiotherapy induces latent postoperative myelosuppression and may lead to intractable infection.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Japanese Committee for Registration of Esophageal Carcinoma Cases, Parameters linked to ten-year survival in Japan of resected esophageal carcinoma. Chest 1989; 96: 1005–11.
Lernt TE, De Leyn P, Coosemans W, Van Raemdonck D, Cuypers P, Van Cleynenbreughel B. Advanced esophageal carcinoma. World J Surg 1994; 18: 379–87.
Japanese society for esophageal diseases. Guidelines for clinical and pathologic studies on carcinoma of the esophagus. 6th ed. Tokyo: Kanehara, 1984: 24. (in Japanese).
Hermank P, Henson DE, Huttier RVP. TNM Supplement 1993. Berlin: Springer-Verlag, 1993: 119–20.
Siewert JR, Roder JD. Lymphadenectomy in esophageal cancer surgery. Dis Esophag. 1992; 5: 91.
Ishida K, Iizuka T, Ando N, Ide H. Phase II study of chemoradiotherapy for advanced squamous cell carcinoma of the thoracic esophagus: 9 Japanese institutions trial. Jpn J Clin Oncol 1996; 26: 310–5.
Meng YG, Martin TG, Peterson ML, Shuman MA, Cohen RL, Wong WL. Circulating thrombopoietin concentration in thrombocytopenic patients, including cancer patients following chemotherapy, with or without peripheral blood progenitor cell transplantation. Br J Haematol 1996; 95: 535–41.
Author information
Authors and Affiliations
Additional information
Read at the Fifty-first Annual Meeting of The Japanese Association for Thoracic Surgery Panel Discussion, Tokyo, October 2–4, 1998.
Rights and permissions
About this article
Cite this article
Ishida, K., Koeda, K., Sato, N. et al. Problems in neoadjuvant chemoradiotherapy preceding surgery for advanced squamous cell carcinoma of the thoracic esophagus. Jpn J Thorac Caridovasc Surg 47, 262–266 (1999). https://doi.org/10.1007/BF03218007
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF03218007